AVO Q3 Earnings Beat on Farming Strength and Calavo Contribution

Mission Produce reported fiscal Q3 2026 adjusted EPS of $0.16, beating the $0.10 consensus by 60%, while revenue rose 25.8% year over year to $450 million, 22.3% above expectations. Adjusted EBITDA was essentially flat at $32.4 million, above the high end of prior guidance, but gross margin declined 270bps to 9.9% as avocado pricing fell amid elevated supply. The company reaffirmed second-half EBITDA guidance of $84 million-$88 million and expects Q4 EBITDA of $52 million-$55 million, supported by Peru sales, seasonal blueberry activity, a full-quarter Calavo contribution, and more than $30 million in annualized Calavo synergies.

Analysis

The earnings beat is unlikely to justify a durable multiple expansion without evidence that acquired distribution revenue converts into cash earnings. Volume-led growth alongside lower realized pricing and margin compression implies limited operating leverage in the core business; the fourth-quarter EBITDA step-up therefore rests heavily on seasonal crop timing, mix and integration execution rather than a demonstrated improvement in normalized unit economics. The market should discount the headline revenue surprise until gross margin recovers while acquisition-related costs roll off.

The key second-order issue is balance-sheet flexibility. Net debt is roughly $353 million against a business with material seasonal working-capital needs, while operating cash conversion has deteriorated; this makes the equity unusually sensitive to a modest miss in fourth-quarter pricing, crop quality, or inventory turns. A higher synergy target is constructive only if it appears in run-rate SG&A and EBITDA rather than being offset by continued integration charges, purchase-accounting effects, or additional working-capital investment.

AVO has a relative advantage over smaller avocado participants through sourcing, logistics and retail distribution, so sustained low fruit prices could ultimately accelerate share gains and pressure less diversified competitors such as CVGW. Contrarily, the apparent near-term setup may be too optimistic: a large back-end-loaded Peru sales concentration creates a single-quarter execution risk, and lower industry pricing can make a volume beat economically hollow. The thesis turns constructive over 6-18 months only if management demonstrates synergy capture, deleveraging and stable margins through a normalized supply cycle.

Key Decisions for Investors

• Do not chase AVO on the earnings reaction. Establish a 1-3 month watch position only after fourth-quarter results confirm EBITDA of at least $52 million and show gross-margin stabilization versus the third quarter; upside is a synergy-driven rerating, while downside is a guidance reset if price/volume mix disappoints.
• For existing AVO exposure, reduce or hedge into any sharp post-results strength until cash conversion improves. A falsification trigger for the bullish case is net debt remaining near current levels after the seasonal fourth-quarter cash harvest, or fiscal-2027 synergy guidance failing to translate into lower SG&A as a percent of sales.
• Monitor a relative-value long AVO / short CVGW only after confirming comparable valuation, borrow availability and each company's post-transaction asset exposure. The pair works if AVO's integrated network captures retail share and synergies during oversupply; exit if avocado pricing rebounds sharply, benefiting CVGW's more direct commodity exposure disproportionately.
• Avoid treating CHEF, UNFI or MED as direct read-through trades. Their earnings sensitivity is driven by foodservice demand, distributor procurement and weight-loss channel conditions rather than avocado pricing; the article provides no incremental fundamental catalyst for those names.